Avaleht › Äge bifentüübiline leukeemia › Oklahoma

Äge bifentüübiline leukeemia kliinilised uuringud osariigis Oklahoma

5 uuringut haiguse Äge bifentüübiline leukeemia jaoks otsivad osalejaid osariigis Oklahoma.

Linnad osariigis Oklahoma

Ametlik uuringutekst (inglise keeles)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

University of Oklahoma Health Sciences Center, Oklahoma City

VärbamineFaas 2

365 Days · Kõik sood · Uuendatud 25. sept 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

University of Oklahoma Health Sciences Center, Oklahoma City
Saint Francis Children's Hospital, Tulsa

VärbamineFaas 3

365 Days – 25 Years · Kõik sood · Uuendatud 25. aug 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

University of Oklahoma Health Sciences Center, Oklahoma City

VärbamineFaas 1/2

Kuni 22 aastane · Kõik sood · Uuendatud 25. aug 2026 · NCT04726241

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

Saint Francis Children's Hospital, Tulsa

VärbamineFaas 2

Vanused 1–18 · Kõik sood · Uuendatud 10. aug 2026 · NCT06390319

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Saint Francis Children's Hospital, Tulsa

VärbamineFaas 4

Vanused 1–18 · Kõik sood · Uuendatud 14. juuli 2026 · NCT06289673

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.